Why the study?
Has the 5-year survival of patients with malignant hypertension improved over the past 40 years with modern antihypertensive therapy?
Has the 5-year survival of patients with malignant hypertension improved over the past 40 years with modern antihypertensive therapy?
Five-year survival for malignant hypertension has significantly improved over the past 40 years, likely due to better blood pressure management and newer medications.
No takes yet. Share an insight, caveat, or question.
May indicate benefits of modern BP control in malignant hypertension; extends observational trends but leaves causality and optimal regimens open.
Lane et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: